Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

MEDIGATE

MEDI:GATE NEWS Bridge Biotherapeutics Begins Administration of Patients in Clinical Participation of BBT-176, a Next-Generation New Lung Cancer Drug Candidate

MEDI:GATE NEWS Bridge Biotherapeutics Begins Administration of Patients in Clinical Participation of BBT-176, a Next-Generation New Lung Cancer Drug Candidate

MEDI:GATE NEWS GI Innovation, Interpark Bio CEO Hong Jun-ho recruited…  Attracting 20 billion investment

MEDI:GATE NEWS GI Innovation, Interpark Bio CEO Hong Jun-ho recruited… Attracting 20 billion investment

MEDI:GATE NEWS ST Pharm, established Revatio for RNA and CAR-NKT development in San Diego, USA

MEDI:GATE NEWS ST Pharm, established Revatio for RNA and CAR-NKT development in San Diego, USA

MEDI:GATE NEWS Antibody-based novelty novelty with a variety of potential applications, beyond SCF/c-KIT targets, we will also catch impregnable RAS

MEDI:GATE NEWS Antibody-based novelty novelty with a variety of potential applications, beyond SCF/c-KIT targets, we will also catch impregnable RAS

MEDI:GATE NEWS Curacle confirms efficacy and safety in Phase 2a clinical trial for new drug for diabetic nephropathy

MEDI:GATE NEWS Curacle confirms efficacy and safety in Phase 2a clinical trial for new drug for diabetic nephropathy

MEDI:GATE NEWS Held a regular shareholders’ meeting of Huzel, aims to double the overseas market this year

MEDI:GATE NEWS Held a regular shareholders’ meeting of Huzel, aims to double the overseas market this year

MEDI:GATE NEWS Binex, non-preservative pharmaceuticals, arbitrarily use additives

MEDI:GATE NEWS Binex, non-preservative pharmaceuticals, arbitrarily use additives

MEDI:GATE NEWS Cheil Pharmaceuticals 14% cash dividend decision and systematic new drug development promotion

MEDI:GATE NEWS Cheil Pharmaceuticals 14% cash dividend decision and systematic new drug development promotion

MEDI:GATE NEWS Yuhan Corporation, additionally invested 10 billion won in April Bio, listed as the 2nd largest shareholder

MEDI:GATE NEWS Yuhan Corporation, additionally invested 10 billion won in April Bio, listed as the 2nd largest shareholder

MEDI:GATE NEWS Dongkuk Pharm launches Co&Tech, an allergen blocker

MEDI:GATE NEWS Dongkuk Pharm launches Co&Tech, an allergen blocker

MEDI:GATE NEWS Attracting 1000-bed general hospital in Wirye New City…

MEDI:GATE NEWS Attracting 1000-bed general hospital in Wirye New City…

MEDI:GATE NEWS AI predicts the outcome after deep brain stimulation

MEDI:GATE NEWS AI predicts the outcome after deep brain stimulation

Older posts
Page1 Page2 … Page6 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en